Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Assessment of the Immunogenicity and Safety of PENTAXIM in Philippines.

Trial Profile

Assessment of the Immunogenicity and Safety of PENTAXIM in Philippines.

Completed
Phase of Trial: Phase IV

Latest Information Update: 16 Mar 2013

At a glance

  • Drugs Hib-DTaP-poliovirus vaccine (Primary) ; Hepatitis B vaccine recombinant
  • Indications Diphtheria; Haemophilus infections; Hepatitis B; Pertussis; Poliomyelitis; Tetanus
  • Focus Adverse reactions; Pharmacodynamics
  • Sponsors Sanofi
  • Most Recent Events

    • 22 Apr 2008 Status changed from in progress to completed, according to clinicaltrials.gov.
    • 17 Dec 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top